What This Document Is
This document is a chapter focused on the assessment and management of patients with inflammatory rheumatic disorders. It provides an overview of several specific conditions – rheumatoid arthritis, systemic lupus erythematosus, scleroderma, polymyositis, Sjögren syndrome, polymyalgia rheumatica, giant cell arteritis, and gout – all characterized by inflammation affecting joints, muscles, and connective tissues. The chapter explores the common challenges these diseases present, including limitations in mobility, pain, fatigue, and potential systemic complications.
Why This Document Matters
This chapter is essential for nursing students and healthcare professionals involved in the care of patients with chronic autoimmune and inflammatory conditions. It’s used within a Medical-Surgical Nursing II course to build a foundational understanding of these complex diseases, their impact on patients’ lives, and the principles guiding their care. Understanding these conditions is crucial for providing effective, patient-centered nursing interventions.
Common Limitations or Challenges
This chapter serves as an introduction and overview. It does *not* provide detailed treatment protocols, specific medication dosages, or in-depth case studies. It also doesn’t cover all possible rheumatic diseases – over 100 exist – but focuses on the most prevalent ones. Users will still need additional resources for comprehensive clinical practice guidelines and specialized knowledge.
What This Document Provides
This chapter includes:
* An overview of the pathophysiology of inflammatory rheumatic disorders, highlighting the roles of inflammation, autoimmunity, and degeneration.
* Key signs and symptoms common to these conditions, including pain, swelling, limited movement, and fatigue.
* Guidance on performing a relevant health history and physical assessment, with a focus on musculoskeletal and systemic findings.
* A table outlining key laboratory studies used in diagnosis and monitoring (creatinine, ESR, hematocrit, WBC count, uric acid, ANA, anti-DNA).
* Normal ranges for common lab values to aid in interpretation.
This preview does *not* include the full content of Table 34-1, detailed nursing care plans, pharmacological information, or specific diagnostic criteria for each disease.
